Susquehanna International Group, LLP Xeris Biopharma Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 637,782 shares of XERS stock, worth $3.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
637,782
Previous 107,344
494.15%
Holding current value
$3.13 Million
Previous $363,000
864.46%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XERS
# of Institutions
204Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $666M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...